ERecord Management, Inc. Stocks

$ 0Last Updated 20.03.2026

Issuer Rating

Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 22.59M

Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

ERecord Management, Inc. operates as a healthcare consulting company. It offers EMR solutions to healthcare providers in terms of health information systems and services; PMS solutions for enterprise appointment scheduling; and MRI solutions, which include MRI technology and PACS system software, as well as various installation, management, and daily staffing. The company also provides training, implementation, technical support, remote troubleshooting, and corporate office training services. ERecord Management focuses on solutions for electronic medical records, practice management systems, information technology security and audit services, and various other components of HIPAA compliance requirements. The company was founded in 2001. It was formerly known as R-Tec Technologies, Inc. and changed its name to ERecord Management, Inc. in January 2008. ERecord Management is based in Oak Park, California.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks